Jaguar Health, Inc. (JAGX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. on May 4, 2026. The report addresses a material event regarding the Company's compliance with The Nasdaq Stock Market LLC listing requirements following a recent corporate action.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. The only quantitative data disclosed relates to share counts:
- Post-Split Publicly Held Shares (Initial): Approximately 401,226 shares.
- Current Issued and Outstanding Shares: 513,974 shares.
- Current Publicly Held Shares: 513,939 shares.
Material Changes
On April 30, 2026, the Company effected a 1-for-35 reverse stock split. Consequently, on May 1, 2026, Nasdaq notified the Company of non-compliance with Listing Rule 5550(a)(4) due to having fewer than the required 500,000 publicly held shares. Additionally, the Company was noted as non-compliant with the minimum $1.00 bid price requirement under Listing Rule 5810(c)(3)(A).
On May 4, 2026, certain third-party investors exercised existing pre-funded warrants to purchase Common Stock. This action increased the number of publicly held shares to 513,939, exceeding the 500,000 share threshold.
Outlook, Risks, and Management Commentary
The Company is currently awaiting formal confirmation from the Nasdaq Listing Qualifications Department that it has evidenced compliance with the Publicly Held Shares Requirement. Management notes that full compliance with the bid price requirement will only be achieved after the share count deficiency is cured and the Company subsequently evidences a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days (potentially extendable to 20 days).
Investor Verification Checklist
- Confirm receipt of formal compliance confirmation from Nasdaq regarding the Publicly Held Shares Requirement.
- Monitor the daily closing bid price of JAGX stock to ensure it meets the $1.00 threshold for the required consecutive business days.
- Verify the final status of the pre-funded warrant exercises and their impact on total share count.